Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR

被引：0
|
作者：
Brevet, M. [1 ]
Arcila, M. [1 ]
Ladanyi, M. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1781
引用
收藏
页码：399A / 399A
页数：1
相关论文
共 50 条
  • [1] Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR
    Brevet, Marie
    Arcila, Maria
    Ladanyi, Marc
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (02): : 169 - 176
  • [2] Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR
    Brevet, M.
    Arcila, M.
    Ladanyi, M.
    LABORATORY INVESTIGATION, 2010, 90 : 399A - 399A
  • [3] Assessment of EGFR Mutation Status in Needle Biopsies and Cytology Specimens of Lung Adenocarcinoma by Immunohistochemistry Using Antibodies to the Two Major Forms of Mutant EGFR
    Ang, D. C.
    Brevet, M.
    Ladanyi, M.
    Zakowski, M. F.
    MODERN PATHOLOGY, 2010, 23 : 87A - 87A
  • [4] Assessment of EGFR Mutation Status in Needle Biopsies and Cytology Specimens of Lung Adenocarcinoma by Immunohistochemistry Using Antibodies to the Two Major Forms of Mutant EGFR
    Ang, D. C.
    Brevet, M.
    Ladanyi, M.
    Zakowski, M. F.
    LABORATORY INVESTIGATION, 2010, 90 : 87A - 87A
  • [5] Detection of EGFR Mutations in Lung Adenocarcinoma by Immunohistochemistry Using Mutant Specific Antibodies: Are We There Yet?
    Arora, K.
    Zhang, W.
    Fukuoka, J.
    Kitano, H.
    Jagirdar, J.
    LABORATORY INVESTIGATION, 2012, 92 : 471A - 471A
  • [6] Detection of EGFR Mutations in Lung Adenocarcinoma by Immunohistochemistry Using Mutant Specific Antibodies: Are We There Yet?
    Arora, K.
    Zhang, W.
    Fukuoka, J.
    Kitano, H.
    Jagirdar, J.
    MODERN PATHOLOGY, 2012, 25 : 471A - 471A
  • [7] Immunohistochemistry Profile Predicts EGFR Mutation Status in Lung Adenocarcinoma
    Li, Wencheng
    Niehaus, Angela G.
    O'Neill, Stacey S.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2020, 28 (05) : 502 - 506
  • [8] Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma
    Tseng, Jeng-Sen
    Yang, Tsung-Ying
    Tsai, Chi-Ren
    Chen, Kun-Chieh
    Hsu, Kuo-Hsuan
    Tsai, Meen-Hsin
    Yu, Sung-Liang
    Su, Kang-Yi
    Chen, Jeremy J. W.
    Chang, Gee-Chen
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (04) : 603 - 610
  • [9] EGFR Mutation Specific Antibodies Can Detect the Majority of EGFR TKI Sensitizing Mutations in Adenocarcinoma of the Lung
    Solomides, C. C.
    Draganova-Tacheva, R.
    Bibbo, M.
    Ren, S.
    Shi, Y.
    Palazzo, I. E.
    Birbe, R.
    O'Neill, R.
    Peiper, S. C.
    Wang, Z-X
    LABORATORY INVESTIGATION, 2014, 94 : 495A - 495A
  • [10] EGFR Mutation Specific Antibodies Can Detect the Majority of EGFR TKI Sensitizing Mutations in Adenocarcinoma of the Lung
    Solomides, C. C.
    Draganova-Tacheva, R.
    Bibbo, M.
    Ren, S.
    Shi, Y.
    Palazzo, I. E.
    Birbe, R.
    O'Neill, R.
    Peiper, S. C.
    Wang, Z-X
    MODERN PATHOLOGY, 2014, 27 : 495A - 495A
12345